The mechanisms of ceramide action in obesity and metabolic disorders are inhibition of insulin signaling,19 reduction of fat thermogenesis and browning,43 and inflammatory response.44 The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.